Outpace Bio Announces $144M Oversubscribed Series B Financing to Advance AI-powered Cell Therapies into Clinical Development

American Association for Cancer Research (AACR)

OPB-101: An optimized mesothelin-specific CAR T cell product expressing CD8-targeted IL-2/15 and engineered to resist T cell exhaustion

Globe Newswire

Outpace Bio Announces Multiple Presentations at the 2024 American Association of Cancer Research (AACR) Annual Meeting

Society for Immunotherapy of Cancer (SITC)

Protein design and inducible expression allow context-dependent, localized IL-12 activity to enhance solid tumor T cell therapies

Globe Newswire

Outpace Bio to present new data on tumor-restricted IL-12 designed leveraging OutSmart technology to enhance solid tumor T cell therapies at SITC 2023

Cancer Cell

Building smart CAR T cell therapies: The path to overcome current challenges

GeekWire

Seattle startups move into growing science cluster in South Lake Union

American Society for Gene & Cell Therapy (ASGCT)

OutSmart™ IL-2/15 Safely Stimulates CAR T Proliferation and Persistence in the Tumor while Limiting Regulatory T Cell Activation

GeekWire

How AI is changing the way scientists engineer drugs, biosensors, enzymes and more